SHL Telemedicine Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SMDCF research report →
About the company
SHL Telemedicine Ltd. , an Israeli company, develops and globally markets a range of personal telemedicine solutions across Israel, Europe, and other international territories. The firm specializes in cardiac monitoring devices, offering products such as SmartHeart, a mobile 12-lead ECG instrumental in detecting heart attacks, alongside the CardioSen'C cellular-digital 12-lead ECG transmitter, the portable Cardio'B for 12-lead ECGs, and the handheld Cardio Beeper 12/12, which transmits comprehensive ECG readings to monitoring centers.
- CEO
- Erez Nachtomy
- IPO
- 2016
- Employees
- 402
- HQ
- Tel Aviv, IL
Price Chart
- Market Cap
- $280.87M
- P/E
- -1.20
- P/S
- 0.59
- P/B
- 0.86
- EV/EBITDA
- -2.32
- Div Yield
- 0.00%
- Gross Margin
- 45.43%
- Op Margin
- -47.19%
- Net Margin
- -49.48%
- ROE
- -49.82%
- ROIC
- -45.76%
- 52W High
- $17.15
- 52W Low
- $13.40
- 50D MA
- $17.15
- 200D MA
- $17.15
- Beta
- 0.53
- Avg Volume
- 0
Get TickerSpark's AI analysis on SMDCF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SMDCF coverage
Recent articles, reports, and earnings notes.
No research on SMDCF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SMDCF report →Similar companies
Peers in the same neighborhood.